Fda risks
January 5th 2009
   |
|
Fda risks
FDA Issues Interim Safety and Risk Assessment of Melamine and Melamine ...
FDA Issues Interim Safety and Risk Assessment of Melamine and Melamine-related Compounds in Food (more...)
FDA: Risks of new asthma drugs vary
WASHINGTON (AP) - The blockbuster asthma drug Advair does not appear to have an increased risk of serious complications seen with similar new medicines, federal health officials ... (more...)
FDA: Risks of new asthma drugs vary
(AP) -- The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health officials ... (more...)
U S Food and Drug Administration Home Page
FDA Requires Warnings about Risk of Suicidal Thoughts and Behavior for Antiepileptic Medications ... U.S. Food and Drug Administration ยท 5600 Fishers Lane Rockville, MD 20857 ... (more...)
FDA/CFSAN Food Risks: Perception vs. Reality - table of contents
U. S. Food and Drug Administration Center for Food Safety and Applied Nutrition FDA/IFIC Booklet, 1993 FOOD RISKS: PERCEPTION VS. (more...)
FDA: Risks of new asthma drugs vary
WASHINGTON -- The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health ... (more...)
FDA: Risks of new asthma drugs vary
The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health officials said ... (more...)
FDA advisers weigh risks of asthma drugs
WASHINGTON (AP) - In recent years, millions of asthma patients have started using long-acting drugs to help them breathe more normally, allowing for nights of uninterrupted sleep ... (more...)
FDA/CFSAN - Risk Assessment for Food Terrorism and Other Food Safety ...
Risk Assessment for Food Terrorism and Other Food Safety Concerns (more...)
FDA: Risks Of New Asthma Drugs Vary
WASHINGTON (AP) -- The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health ... (more...)